New accurate diagnostic test for swine H1N1 influenza using RT-PCR technologyJune 10, 2009A new, easy-to-perform method for detecting both seasonal influenza A virus and the emerging H1N1 swine-derived influenza A virus in human clinical samples offers a fast, sensitive, and cost-effective diagnostic test that runs on standard laboratory equipment. This timely and broadly applicable molecular technique is described in an article published online ahead of print in Vector-Borne and Zoonotic Diseases, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The article is available free online at www.liebertpub.com/vbz The recent emergence and global spread of a new swine flu virus highlights the urgent need for a reliable diagnostic test that can discriminate the H1N1 influenza virus from other strains and can be readily implemented in clinical testing laboratories. The molecular strategy described in the article in Vector-Borne and Zoonotic Diseases is based on proven and widely used Real-Time, Polymerase Chain Reaction (RT-PCR) technology. The authors of the report entitled "A Simple Method for Molecular Detection of Swine-Origin and Human-Origin Influenza A Virus" describe the development of a new molecular probe that improves on the existing PCR assay used to diagnose seasonal influenza and enables detection of both the seasonal and H1N1 influenza A viruses in the same patient sample using a simple test protocol. Laetitia Ninove and colleagues from Université de la Méditerranée and Institut de Recherche pour le Développement (Marseille, France), Hôpitaux de Marseille, CEH Oxford (UK), and EHESP School of Public Health (Rennes, France) provide data to support the sensitivity and effectiveness of the SYBR Green RT-PCR one-step assay used for screening clinical samples to detect the presence of influenza A virus. In positive samples this is followed by the addition of two probes that are able to discriminate between the seasonal and swine H1N1 viruses to yield a definitive diagnosis. Early, accurate identification of infected individuals will expedite appropriate antiviral therapy and enhance control and containment efforts. Furthermore, this new molecular test specifically amplifies and characterizes the viral genetic material, enabling rapid detection of new viral strains as they evolve. Using these genetic sequence data and making minor alterations to the PCR primers used in the assay, the test could be easily modified to detect newly emerging viral variants, including avian influenza strains. "Early recognition of new influenza strains is vitally important for implementing effective control measures to limit spread. This cost-effective, comprehensive, and rapid test is a highly significant contribution to diagnostics that will greatly enhance our capacity to deal with future influenza outbreaks," says Stephen Higgs BSc, PhD, FRES, Editor-in-Chief of Vector-Borne and Zoonotic Diseases, and Associate Professor, Department of Pathology, Center for Biodefense & Emerging Infectious Diseases, Sealy Center for Vaccine Development and WHO Collaborating Center for Tropical Diseases, University of Texas Medical Branch, Galveston. Mary Ann Liebert, Inc./Genetic Engineering News |
|||||||||||||||||||||
| Related H1N1 Current Events and H1N1 News Articles When should flu trigger a school shutdown? As flu season approaches, parents around the country are starting to face school closures. But how bad should an influenza outbreak be for a school to shut down? Sneezing in times of a flu pandemic The swine flu (H1N1) pandemic has received extensive media coverage this year. The World Health Organization, in addition to providing frequent updates about cases of infection and death tolls, recommends hyper vigilance in daily hygiene such as frequent hand washing or sneezing into the crook of our arms. Rice U. lab leads hunt for new zeolites In all the world, there are about 200 types of zeolite, a compound of silicon, aluminum and oxygen that gives civilization such things as laundry detergent, kitty litter and gasoline. But thanks to computations by Rice University professor Michael Deem and his colleagues, it appears there are -- or could be -- more types of zeolites than once thought. Initial Results Show Pregnant Women Mount Strong Immune Response To One Dose of 2009 H1N1 Flu Vaccine Healthy pregnant women mount a robust immune response following just one dose of 2009 H1N1 influenza vaccine, according to initial results from an ongoing clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health. Pandemic flu vaccine campaigns may be undermined by coincidental medical events The effectiveness of pandemic flu vaccination campaigns - like that now underway for H1N1 - could be undermined by the public incorrectly associating coincidental and unrelated health events with the vaccines. Scientists discover influenza's Achilles heel: Antioxidants As the nation copes with a shortage of vaccines for H1N1 influenza, a team of Alabama researchers have raised hopes that they have found an Achilles' heel for all strains of the flu-antioxidants. TGen seeks emergency FDA approval of new swine flu test The Phoenix-based non-profit Translational Genomics Research Institute (TGen) announced today that, along with a business collaborator, it will submit a request to the U.S. Food and Drug Administration for emergency use of a new test to diagnose the 2009 H1N1 swine flu virus. Lessons from flu seasons past Pregnant women who catch the flu are at serious risk for flu-related complications, including death, and that risk far outweighs the risk of possible side effects from injectable vaccines containing killed virus, according to an extensive review of published research and data from previous flu seasons. Swine flu vaccine must be free and safe for high uptake Almost half of adults surveyed in Summer 2009 in Hong Kong (45%) say they would take up free swine flu vaccination. Triple-Combo Drug Shows Promise Against Antiviral-Resistant Swine Flu, UAB Researcher Says An experimental drug cocktail that includes three prescriptions now widely available offers the best hope in developing a single agent to treat drug-resistant H1N1 swine flu, says a virology researcher in the University of Alabama Birmingham (UAB) Division of Pediatric Infectious Diseases. More H1N1 Current Events and H1N1 News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||